Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
Designing and testing the activities of TAL effector nucleases
Yanni Lin, Thomas J Cradick, Gang Bao
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
High-throughput cellular screening of engineered nuclease activity using the single-strand annealing assay and luciferase reporter
Thomas J Cradick, Christopher J Antico, Gang Bao
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
Identification of off-target cleavage sites of zinc finger nucleases and TAL effector nucleases using predictive models
Eli J Fine, Thomas J Cradick, Gang Bao
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2016
The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
Ciaran M Lee, Thomas J Cradick, Gang Bao
Science China. Life Sciences
|
October 31, 2012
Engineering imaging probes and molecular machines for nanomedicine
Sheng Tong, Thomas J Cradick, Yan Ma, et al.
Nucleic Acids Research
|
August 14, 2013
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J Cradick, Eli J Fine, Christopher J Antico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2016
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing
Ciaran M Lee, Thomas J Cradick, Eli J Fine, et al.
BMC Bioinformatics
|
May 17, 2011
ZFN-site searches genomes for zinc finger nuclease target sites and off-target sites
Thomas J Cradick, Giovanna Ambrosini, Christian Iseli, et al.
Annals of Biomedical Engineering
|
December 4, 2013
Nanomedicine: tiny particles and machines give huge gains
Sheng Tong, Eli J Fine, Yanni Lin, et al.
Molecular Therapy. Nucleic Acids
|
December 3, 2014
COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Thomas J Cradick, Peng Qiu, Ciaran M Lee, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
Designing and testing the activities of TAL effector nucleases
Yanni Lin, Thomas J Cradick, Gang Bao
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
High-throughput cellular screening of engineered nuclease activity using the single-strand annealing assay and luciferase reporter
Thomas J Cradick, Christopher J Antico, Gang Bao
Methods in Molecular Biology (Clifton, N.J.)
|
February 22, 2014
Identification of off-target cleavage sites of zinc finger nucleases and TAL effector nucleases using predictive models
Eli J Fine, Thomas J Cradick, Gang Bao
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2016
The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
Ciaran M Lee, Thomas J Cradick, Gang Bao
Science China. Life Sciences
|
October 31, 2012
Engineering imaging probes and molecular machines for nanomedicine
Sheng Tong, Thomas J Cradick, Yan Ma, et al.
Nucleic Acids Research
|
August 14, 2013
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J Cradick, Eli J Fine, Christopher J Antico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2016
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing
Ciaran M Lee, Thomas J Cradick, Eli J Fine, et al.
BMC Bioinformatics
|
May 17, 2011
ZFN-site searches genomes for zinc finger nuclease target sites and off-target sites
Thomas J Cradick, Giovanna Ambrosini, Christian Iseli, et al.
Annals of Biomedical Engineering
|
December 4, 2013
Nanomedicine: tiny particles and machines give huge gains
Sheng Tong, Eli J Fine, Yanni Lin, et al.
Molecular Therapy. Nucleic Acids
|
December 3, 2014
COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Thomas J Cradick, Peng Qiu, Ciaran M Lee, et al.
Page
of 3